Latest News and Press Releases

In today’s WTNH health headlines, a physician-scientist tells us about liver cancer care here in New Haven, what your life may look like after certain liver cancer therapies, and what the future of liver cancer care will look like soon. Dr. Julius Chapiro, Yale Medicine interventional radiologist, professor at Yale School of Medicine, and member of Yale Cancer Center, joined WTNH's Good Morning Connecticut at 9 a.m. to discuss.

There are now multiple phase 3 studies on combination transarterial chemoembolization (TACE) and immunotherapy showing a significant benefit over TACE alone. How do these findings change the hepatocellular carcinoma (HCC) treatment algorithm? In this multidisciplinary episode of the BackTable Podcast, Dr. Richard Finn (Medical Oncologist at UCLA) and Dr. Julius Chapiro (Interventional Radiologist at Yale University) join host Dr. Chris Beck to discuss immunotherapy, TACE, emerging trends in HCC treatment, and the future of the field.

Howie and Harlan are joined by Julius Chapiro to discuss advances in the use of machine learning and molecular imaging to understand and treat liver cancer and his work as the director of Yale’s Center for Minimally Invasive Therapies. Harlan reports on a medical journal paper that highlights positive outcomes while ignoring negative ones; Howie warns of the impact of private equity ownership of medical practices.

Host Roger Tomihama, MD, speaks with interventional radiologist Julius Chapiro, MD, about the future of artificial intelligence in interventional radiology, his work with AI in liver cancer treatment, and more.